Pfizer completes $6.7B Arena deal after clock runs out on FTC objection period
Pfizer’s $6.7 billion acquisition of Arena Pharmaceuticals is officially closed.
The two completed the buyout Friday morning, Pfizer said in a press release, apparently …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.